Term ends Jun 3, 2033 · High confidence
20-year base term ends Jun 3, 2033
Held by Pharmacyclics LLC
Filed Dec 21, 2016 as application 15/386,118 · Granted Jul 25, 2017
Base term, 20 years from filing
Today
2013
2033
Clock starts
Jun 3, 2013
Jun 3, 2013
Term ends
Jun 3, 2033
Jun 3, 2033
Granted
Jul 25, 2017
Jul 25, 2017
base term
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 9,540,382, to Jun 3, 2033. The term already ends on or before that date, so the cap shortened nothing.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
20
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 3, 2013, when application PCT/US2013/043888, the earliest non-provisional in its chain, was filed (this one was filed Dec 21, 2016) | Jun 3, 2033 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 9,540,382) | resolves to Jun 3, 2033, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jun 3, 2033 | High confidence |
This family
| Application PCT/US2013/043888 | PCT application no patent term | no patent term |
| US 9,540,382 | In force Aug 2033 | Aug 2033 |
| US 9,713,617 | this patent Jun 2033 | Jun 2033 |
| US 9,725,455 | In force Jun 2033 | Jun 2033 |
| Application 15/645,319 | Abandoned not computed | not computed |
| US 9,828,383 | In force Jun 2033 | Jun 2033 |
| Application 15/887,744 | Abandoned not computed | not computed |
| US 10,106,548 | In force no later than Jun 2033 | no later than Jun 2033 |
8 of 20 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 4, 2017 Reel 40838, frame 616 | Smyth, Mark; Goldman, Erick | Pharmacyclics, Inc. | Assignment of Assignor's Interest |
| Jan 4, 2017 Reel 40838, frame 618 | Wirth, David D. | Nanoscale Combinatorial Synthesis, Inc. | Assignment of Assignor's Interest |
| Jan 4, 2017 Reel 40838, frame 620 | Nanoscale Combinatorial Synthesis, Inc. | Pharmacyclics, Inc. | Assignment of Assignor's Interest |
| Jan 4, 2017 Reel 40838, frame 630 | Purro, Norbert | Pharmacyclics, Inc. | Assignment of Assignor's Interest |
| Jan 4, 2017 Reel 40838, frame 716 | Pharmacyclics, Inc.; Oxford Amherst LLC; Pharmacyclics LLC | Pharmacyclics LLC | Merger and Change of Name |
| Jan 4, 2017 Reel 40839, frame 499 | Oxford Amherst Corporation; Pharmacyclics, Inc. | Pharmacyclics, Inc. | Merger |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jun 2033
Term ends Jun 3, 2033. Maintenance fees still fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 9,540,382, ends no earlier than this term, so it caps nothing.
Citations
21
later US patents cite this one
That is top 25% of utility patents granted in 2017 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.